Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Tokyo - Delayed Quote JPY

MEDINET Co., Ltd. (2370.T)

Compare
31.00
+1.00
+(3.33%)
As of 2:35:13 PM GMT+9. Market Open.
Loading Chart for 2370.T
  • Previous Close 30.00
  • Open 31.00
  • Bid 31.00 x --
  • Ask 32.00 x --
  • Day's Range 30.00 - 33.00
  • 52 Week Range 28.00 - 57.00
  • Volume 1,825,400
  • Avg. Volume 818,900
  • Market Cap (intraday) 8.2B
  • Beta (5Y Monthly) 0.66
  • PE Ratio (TTM) --
  • EPS (TTM) -5.04
  • Earnings Date May 8, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. Its solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy. The company also manufactures regenerative medical/investigational and specified cell products. In addition, its value chain solutions comprise personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management system, quality control and assurance, and technology transfer and process development solutions. The company serves medical institutions, research institutions, and biopharmaceutical companies. MEDINET Co., Ltd. was incorporated in 1995 and is headquartered in Tokyo, Japan.

www.medinet-inc.co.jp

92

Full Time Employees

September 30

Fiscal Year Ends

Recent News: 2370.T

View More

Performance Overview: 2370.T

Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

2370.T
13.89%
Nikkei 225 (^N225)
13.86%

1-Year Return

2370.T
36.73%
Nikkei 225 (^N225)
13.17%

3-Year Return

2370.T
39.22%
Nikkei 225 (^N225)
27.35%

5-Year Return

2370.T
26.19%
Nikkei 225 (^N225)
76.25%

Compare To: 2370.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2370.T

View More

Valuation Measures

Annual
As of 4/9/2025
  • Market Cap

    7.94B

  • Enterprise Value

    3.29B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    10.33

  • Price/Book (mrq)

    1.53

  • Enterprise Value/Revenue

    4.27

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -33.09%

  • Return on Equity (ttm)

    -69.34%

  • Revenue (ttm)

    998M

  • Net Income Avi to Common (ttm)

    -3.05B

  • Diluted EPS (ttm)

    -5.04

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.2B

  • Total Debt/Equity (mrq)

    2.17%

  • Levered Free Cash Flow (ttm)

    -1.55B

Research Analysis: 2370.T

View More

Company Insights: 2370.T

Research Reports: 2370.T

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.